Sve / NASDAQ / Capricor Therapeutics

Capricor Therapeutics

Capricor Therapeutics

Investiraj bez provizije

Kupuj i prodaj dijelnice za samo 1 €

Informacije i statistika

Dnevni raspon
1D−100,00 %
3M−100,00 %
1T−100,00 %
6M−100,00 %
1M−100,00 %
1G−100,00 %
SIMBOL
CAPR
TRŽIŠTE
NASDAQ
ISIN
US14070B3096

Datum

Zatvori

Promjena

Promjena (%)

Otvoreno

Visoko

Nisko

7,59−0,57−7,51 %8,168,347,37
7,53−0,50−6,64 %8,039,107,38
8,03−0,75−9,34 %8,789,497,99
8,41−0,30−3,57 %8,718,988,23
8,30−0,91−10,96 %9,219,358,19
9,53−0,68−7,14 %10,2110,219,25
10,24−0,71−6,93 %10,9510,959,87
11,221,3712,21 %9,8511,239,01
8,87−0,78−8,79 %9,6510,068,85
9,850,717,21 %9,1410,008,55
9,000,293,22 %8,719,118,30
8,60−0,04−0,47 %8,648,698,15
8,920,738,18 %8,198,947,90
8,241,0112,26 %7,238,327,15
7,240,364,97 %6,887,456,67
6,38−0,20−3,13 %6,586,646,14
6,630,395,88 %6,246,936,24
6,230,233,69 %6,006,405,90
6,100,355,74 %5,756,315,67
5,74−0,17−2,96 %5,915,955,68
5,93−0,10−1,69 %6,036,085,80
6,130,335,38 %5,806,355,80
5,88−0,72−12,24 %6,606,755,79
6,610,081,21 %6,536,836,47
6,65−0,16−2,41 %6,816,926,54
6,71−0,50−7,45 %7,217,256,68
7,270,638,67 %6,647,336,64
6,59−0,17−2,58 %6,766,886,47
6,88−0,38−5,52 %7,267,396,87
7,47−0,32−4,28 %7,797,807,45
7,83−0,22−2,81 %8,058,057,69
8,010,121,5 %7,898,177,80
8,100,516,3 %7,598,257,46
7,750,030,39 %7,727,897,47
7,78−1,01−12,98 %8,798,797,37
8,95−0,09−1,01 %9,049,248,77
8,94−0,38−4,25 %9,329,398,84
9,47−0,56−5,91 %10,0310,709,40
8,57−0,14−1,63 %8,718,968,51
8,710,424,82 %8,298,838,15
8,36−0,25−2,99 %8,618,678,30
8,57−0,03−0,35 %8,608,868,27
8,67−0,59−6,81 %9,269,328,53
9,340,293,1 %9,059,488,89
8,90−0,21−2,36 %9,119,278,84
9,06−0,21−2,32 %9,279,358,96
9,420,495,2 %8,939,798,84
8,56−0,01−0,12 %8,579,078,41
8,56−0,27−3,15 %8,838,908,37
8,81−0,38−4,31 %9,199,248,71
8,370,050,6 %8,328,678,26
8,30−0,26−3,13 %8,568,708,18
8,64−0,42−4,86 %9,069,268,61
9,06−0,09−0,99 %9,159,488,81
9,400,000 %9,409,809,26
9,28−0,55−5,93 %9,839,939,14
9,89−0,17−1,72 %10,0610,659,60
10,01−0,76−7,59 %10,7710,999,85
9,910,505,05 %9,4110,249,07
9,59−0,14−1,46 %9,7310,199,47
10,060,888,75 %9,1810,618,90
9,361,1312,07 %8,239,888,05
8,291,0212,3 %7,278,597,27
6,80−1,21−17,79 %8,018,016,34
6,29−0,51−8,11 %6,807,086,01
6,83−0,83−12,15 %7,667,806,83
7,980,8110,15 %7,177,997,15
7,08−0,42−5,93 %7,508,286,76
7,450,577,65 %6,887,596,59
6,65−1,03−15,49 %7,688,146,05
4,21−0,01−0,24 %4,224,424,14
4,190,266,21 %3,934,303,90
3,930,082,04 %3,853,993,73
3,85−0,18−4,68 %4,034,103,80
4,09−0,07−1,71 %4,164,704,05
4,180,307,18 %3,884,213,88
3,93−0,24−6,11 %4,174,313,84
4,170,040,96 %4,134,424,09
4,200,4310,24 %3,774,203,66
3,85−0,20−5,19 %4,054,663,80
4,191,1226,73 %3,074,212,96
6,57−0,21−3,2 %6,787,215,70
6,991,1716,74 %5,827,835,82
19,70−0,01−0,05 %19,7120,1718,30
19,831,316,61 %18,5220,5418,50
18,91−0,81−4,28 %19,7219,9218,76
19,790,291,47 %19,5020,1618,97
19,50−0,18−0,92 %19,6820,1719,00
19,440,673,45 %18,7719,7918,65
19,12−1,27−6,64 %20,3920,4919,00
20,35−0,28−1,38 %20,6320,7619,60
20,680,090,44 %20,5921,0420,27
20,61−0,66−3,2 %21,2721,3820,17
21,51−1,07−4,97 %22,5822,5821,19
22,500,070,31 %22,4322,5221,76
22,25−0,01−0,04 %22,2623,0321,41
22,22−0,32−1,44 %22,5422,7021,82
22,43−1,14−5,08 %23,5723,8521,64
23,21−0,04−0,17 %23,2524,5622,54
23,07−0,98−4,25 %24,0524,2523,04
24,080,220,91 %23,8624,9923,86
23,80−3,21−13,49 %27,0127,0323,49
26,44−0,57−2,16 %27,0127,4025,66
30,401,003,29 %29,4030,9329,29
29,51−0,37−1,25 %29,8829,9929,19
29,600,872,94 %28,7329,9928,53
29,34−0,16−0,55 %29,5030,1928,89
28,380,100,35 %28,2829,2227,65
27,950,672,4 %27,2828,7026,97
26,05−0,79−3,03 %26,8427,0325,60
26,720,682,54 %26,0426,9626,00
25,800,682,64 %25,1226,1225,02
25,04−0,32−1,28 %25,3625,6424,65
25,33−0,67−2,65 %26,0026,4225,01
26,01−0,54−2,08 %26,5526,9725,07
26,16−0,99−3,78 %27,1527,3826,00
26,71−1,17−4,38 %27,8827,9526,56
27,950,180,64 %27,7728,4627,51
27,640,612,21 %27,0327,8626,92
27,34−0,71−2,6 %28,0528,2627,09
28,53−0,99−3,47 %29,5229,5228,03
29,96−0,03−0,1 %29,9930,5029,54
29,11−0,10−0,34 %29,2129,3628,77
29,14−0,28−0,96 %29,4229,8728,89
29,36−0,07−0,24 %29,4329,4528,85
28,87−0,71−2,46 %29,5829,9328,66
29,580,822,77 %28,7629,9228,17
29,011,495,14 %27,5229,1227,08
26,92−1,08−4,01 %28,0028,0026,60
28,01−0,98−3,5 %28,9929,1927,38
28,79−0,32−1,11 %29,1129,8328,53
29,81−0,69−2,31 %30,5030,9229,37
30,33−0,17−0,56 %30,5031,9429,26
31,52−0,06−0,19 %31,5832,0530,92
31,901,605,02 %30,3032,5530,02
30,380,882,9 %29,5031,2728,50
33,94−0,01−0,03 %33,9534,2633,02
34,381,243,61 %33,1434,5032,88
32,96−0,74−2,25 %33,7034,3431,58
33,502,296,84 %31,2133,6431,06
30,91−2,59−8,38 %33,5033,5930,85
33,580,521,55 %33,0634,6432,74
32,46−1,44−4,44 %33,9034,1132,31
33,98−1,02−3 %35,0035,8533,62
35,10−0,20−0,57 %35,3035,4534,13
35,271,403,97 %33,8735,3433,06
33,86−1,14−3,37 %35,0035,0732,86
35,00−0,61−1,74 %35,6135,9934,53
35,340,982,77 %34,3635,4733,76
34,21−0,46−1,34 %34,6736,8233,90
34,70−0,66−1,9 %35,3635,6634,35
34,59−0,70−2,02 %35,2935,3733,44
35,040,220,63 %34,8235,3034,07
34,720,712,04 %34,0134,7733,38
34,543,339,64 %31,2135,9930,90
31,20−0,34−1,09 %31,5431,6829,58
31,610,391,23 %31,2232,1330,98
31,60−1,27−4,02 %32,8733,0031,29
31,970,601,88 %31,3731,9830,33
31,68−0,30−0,95 %31,9833,1431,40
32,113,029,41 %29,0932,3928,91
30,12−0,33−1,1 %30,4531,7429,95
30,401,886,18 %28,5230,4728,29
27,77−1,15−4,14 %28,9229,2727,50
28,90−0,72−2,49 %29,6230,4528,37
29,950,511,7 %29,4430,2429,09
29,900,722,41 %29,1830,4429,04
28,87−0,73−2,53 %29,6029,9128,39
30,100,431,43 %29,6730,3228,15
29,10−2,12−7,29 %31,2232,4529,10
31,170,732,34 %30,4431,2529,40
30,90−0,35−1,13 %31,2531,5030,41
31,190,541,73 %30,6531,8430,14
30,560,040,13 %30,5232,4430,19
30,50−2,50−8,2 %33,0033,0029,40
33,42−0,52−1,56 %33,9434,2132,25
33,571,073,19 %32,5035,0832,50
33,400,902,69 %32,5036,4932,08
30,63−0,18−0,59 %30,8131,4028,99
27,902,498,92 %25,4128,8825,07
25,820,321,24 %25,5025,8625,10
25,50−0,94−3,69 %26,4426,5825,34
25,840,210,81 %25,6326,5225,12
26,860,170,63 %26,6927,5526,30
27,930,200,72 %27,7327,9827,13
27,89−0,51−1,83 %28,4028,4527,45
28,350,361,27 %27,9928,8527,90
27,910,260,93 %27,6528,0327,06
27,87−0,28−1 %28,1529,0827,36
28,51−0,19−0,67 %28,7029,4027,54
29,153,6812,62 %25,4729,2325,07
25,532,549,95 %22,9926,1522,80
23,030,542,34 %22,4923,3422,05
22,45−1,79−7,97 %24,2424,3622,27
23,67−0,33−1,39 %24,0024,4823,23
24,20−0,57−2,36 %24,7725,0823,81
24,63−0,44−1,79 %25,0725,4524,49
25,190,471,87 %24,7225,3124,30
24,721,365,5 %23,3625,2123,23
23,03−1,66−7,21 %24,6924,8022,71
24,50−0,28−1,14 %24,7824,7923,70
24,881,837,36 %23,0524,9222,81
23,091,325,72 %21,7723,0921,75
21,89−0,81−3,7 %22,7023,0021,83
22,611,014,47 %21,6022,7021,06
21,57−2,29−10,62 %23,8623,8621,43
23,52−0,17−0,72 %23,6923,7223,10
23,620,612,58 %23,0123,6822,80
23,20−0,82−3,53 %24,0224,1423,01
24,17−0,17−0,7 %24,3424,7424,08
24,310,451,85 %23,8624,6023,52
24,20−0,91−3,76 %25,1125,7023,58
24,350,190,78 %24,1624,8823,96
24,04−0,64−2,66 %24,6824,6823,53
24,790,281,13 %24,5125,0024,23
24,790,522,1 %24,2725,4424,12
24,511,044,24 %23,4724,8623,24
23,84−2,36−9,9 %26,2026,2023,15
25,55−0,31−1,21 %25,8626,2225,07
26,310,230,87 %26,0826,9325,70
26,131,405,36 %24,7326,4424,66
24,81−3,13−12,62 %27,9428,4924,35
28,31−0,67−2,37 %28,9829,3627,52
28,860,100,35 %28,7629,2428,01
28,96−1,04−3,59 %30,0030,0928,21
30,040,411,36 %29,6330,7129,59
29,690,160,54 %29,5329,9029,20
29,680,792,66 %28,8930,1228,51
28,90−0,18−0,62 %29,0829,7428,59
29,501,575,32 %27,9329,9827,78
27,811,605,75 %26,2129,4426,11
26,190,080,31 %26,1126,9926,04
26,150,311,19 %25,8426,8525,60
26,02−0,03−0,12 %26,0526,7125,78
26,550,652,45 %25,9027,1725,87
26,02−0,53−2,04 %26,5527,0725,59
27,18−0,81−2,98 %27,9928,4727,15
28,670,682,37 %27,9929,2327,51
27,38−0,62−2,26 %28,0028,3427,02
28,561,946,79 %26,6231,4426,24
26,890,170,63 %26,7228,6226,01
25,40−2,99−11,77 %28,3930,5823,05
29,96−0,04−0,13 %30,0040,3721,50
6,36−0,39−6,13 %6,756,786,15
6,651,3019,55 %5,357,155,35
5,350,091,68 %5,265,925,22
5,190,5410,4 %4,655,204,63
4,600,153,26 %4,454,844,30
4,64−0,94−20,26 %5,585,614,40
5,750,122,09 %5,636,005,51
5,69−0,13−2,28 %5,826,015,67
5,770,091,56 %5,685,895,60
5,640,081,42 %5,565,775,54
5,690,091,58 %5,605,995,53
5,600,000 %5,605,825,53
5,77−0,06−1,04 %5,836,035,71
5,87−0,31−5,28 %6,186,545,85
6,200,304,84 %5,906,395,66
5,56−0,44−7,91 %6,006,275,43
5,93−0,35−5,9 %6,286,335,90
6,280,000 %6,286,416,15
6,220,162,57 %6,066,266,03
6,060,010,17 %6,056,416,01
6,07−0,38−6,26 %6,456,466,06
6,510,162,46 %6,356,546,17
6,21−0,55−8,86 %6,766,836,19
6,920,7410,69 %6,187,086,12
6,180,000 %6,186,316,12
6,18−0,02−0,32 %6,206,416,17
6,200,040,65 %6,166,336,05
6,13−0,06−0,98 %6,196,286,11
6,23−0,12−1,93 %6,356,376,10
6,37−0,05−0,78 %6,426,496,32
6,400,071,09 %6,336,566,29
6,250,101,6 %6,156,546,01
6,16−0,59−9,58 %6,756,826,13
6,69−0,03−0,45 %6,726,886,62
6,700,081,19 %6,626,806,46
6,72−0,41−6,1 %7,137,156,70
7,09−0,53−7,48 %7,627,627,06
7,620,111,44 %7,517,817,48
7,48−0,05−0,67 %7,537,707,45
7,50−0,30−4 %7,807,807,44
7,810,536,79 %7,287,877,24
7,36−0,57−7,74 %7,937,937,24
7,97−0,03−0,38 %8,008,067,64
7,820,617,8 %7,217,887,21
7,21−0,20−2,77 %7,417,637,11
7,410,202,7 %7,217,637,16
7,090,689,59 %6,417,276,35
6,52−0,29−4,45 %6,817,326,43
6,190,030,48 %6,166,286,05
6,150,091,46 %6,066,316,06
6,09−0,51−8,37 %6,606,606,08
6,650,223,31 %6,436,666,29
6,400,172,66 %6,236,496,16
6,08−0,13−2,14 %6,216,276,04
6,220,010,16 %6,216,386,11
6,04−0,39−6,46 %6,436,575,98
6,36−0,11−1,73 %6,476,476,27
6,440,335,12 %6,116,526,04
6,33−0,21−3,32 %6,546,616,31
6,480,101,54 %6,386,526,14
6,35−0,28−4,41 %6,636,766,33
6,740,7410,98 %6,006,765,81
5,94−0,38−6,4 %6,326,325,68
6,28−0,03−0,48 %6,316,436,23
6,330,071,11 %6,266,406,19
6,280,000 %6,286,366,18
6,26−0,05−0,8 %6,316,436,17
6,25−0,08−1,28 %6,336,546,20
6,47−0,08−1,24 %6,556,606,30
6,60−0,50−7,58 %7,107,106,50
7,100,081,13 %7,027,296,93
7,01−0,10−1,43 %7,117,236,94
7,17−0,48−6,69 %7,657,676,90
7,67−0,09−1,17 %7,767,997,60
7,70−0,15−1,95 %7,857,997,68
7,960,293,64 %7,677,987,59
7,78−0,45−5,78 %8,238,307,75
8,300,232,77 %8,078,607,92
8,040,222,74 %7,828,087,60
7,81−0,37−4,74 %8,188,337,77
9,071,1612,79 %7,919,437,91
8,070,263,22 %7,818,077,54
7,740,070,9 %7,677,827,52
7,670,000 %7,677,797,35
7,68−0,13−1,69 %7,817,907,20
7,90−0,03−0,38 %7,938,287,72
8,180,182,2 %8,008,557,77
8,180,354,28 %7,838,487,51
6,74−0,29−4,3 %7,037,106,61
6,79−0,23−3,39 %7,027,286,72
7,060,456,37 %6,617,086,43
6,48−0,32−4,94 %6,806,806,29
6,820,192,79 %6,637,076,48
6,520,243,68 %6,286,786,24
6,27−0,63−10,05 %6,906,966,19
6,88−0,28−4,07 %7,167,276,88
7,16−0,09−1,26 %7,257,456,97
7,240,070,97 %7,177,436,83
7,17−0,20−2,79 %7,377,466,95
7,38−0,06−0,81 %7,447,496,85
7,640,658,51 %6,998,636,75
11,40−0,02−0,18 %11,4211,5310,62
11,420,968,41 %10,4611,8710,34
10,170,191,87 %9,9810,299,87
9,900,000 %9,9010,109,65
10,250,111,07 %10,1410,5610,11
10,020,353,49 %9,6710,109,45
9,700,010,1 %9,6910,029,48
9,93−1,22−12,29 %11,1511,199,88
11,150,908,07 %10,2511,5710,00
10,18−0,15−1,47 %10,3310,509,80
10,050,818,06 %9,2410,478,91
9,251,3514,59 %7,909,357,83
7,68−0,32−4,17 %8,008,026,93
8,26−3,13−37,89 %11,3911,466,07
11,94−0,09−0,75 %12,0312,6211,86
12,190,171,39 %12,0213,5011,58
12,380,272,18 %12,1112,4211,75
11,78−1,89−16,04 %13,6713,8011,76
13,940,966,89 %12,9813,9712,67
13,14−1,04−7,91 %14,1814,2612,30
13,890,594,25 %13,3014,2113,05

Povezane rasprave

MarkyBoy212

prije 5 dana

Big Week, good luck everyone

I am still very on the fence on this since the Adcom. I hope we all make money when the decision arrives

MarkyBoy212

prošli tjedan

A new buy rating and 2 maintained buys very nice

A new buy rating and 2 maintained buys very nice, hoping this gets approval after earnings and award

ByronKS

prošli tjedan

Capricor earnings report

See the Capricor Therapeutics earnings report below. Good luck! 🤞🏼🍀 https://web.quartr.com/link/companies/5913/events/732825/report?rp=0&documentId=4012432

MarkyBoy212

prije 2 tjedna

Capricor’s HOPE-3 Phase 3 Cardiac Results for Deramiocel Win American Heart Association Outstanding Research Award in Pediatric Cardiology

Capricor’s HOPE-3 Phase 3 Cardiac Results for Deramiocel Win American Heart Association Outstanding Research Award in Pediatric Cardiology

TerraNova23

prije 2 tjedna

Anyone else think this will fail?

According to Adam Feuerstein, Capricor faces two major risks: Weak Clinical Evidence: The FDA may consider Deramiocel's efficacy data insufficient for approval. Public Pressure on the FDA: Capricor's public statements could suggest concerns about its chances of approval. And there is still the 3-9 vote from before.

MarkyBoy212

prije 2 mjeseca

Will be good to have data out

Capricor Therapeutics to Present HOPE-3 and HOPE-3 Open-Label Extension Data at 2026 World Muscle Society Congress

Prayers

prije 3 mjeseca

This too (and yh I DO wish I did this in CFD lol)

This too (and yh I DO wish I did this in CFD lol)

GGGGM

prije 3 mjeseca

Thank God for this stock today

$CAPR to the rescue, thank you thus far... NFA

kosen

prije 3 mjeseca

This pattern looks exactly like yesterday.

If it completely duplicates yesterday’s pattern, we see 11.5 Today???

kosen

prije 3 mjeseca

What do we think

At a loss now, watching a bit

GGGGM

prije 3 mjeseca

We going up.. The News is here.. NFA.

$CAPR would soar today as the long awaited news is finally here. The FDA accepted a major amendment to Capricor's Biologics License Application (BLA) containing 24-month Phase 3 HOPE-3 extension data. Instead of issuing an immediate rejection, the FDA extended the PDUFA target action date to November 22, 2026. I got in early at $8 and waiting to see above 11 and above.. Note that THIS IS NOT A FINANCIAL ADVICE... NFA

SKM2086

prije 3 mjeseca

PT - $54

I'm going with a conservative $25-30. We're on the right track now. Definitely close to making permanent moves upwards. https://uk.investing.com/news/stock-market-news/oppenheimer-upgrades-capricor-stock-rating-on-regulatory-update-93CH-4846076

MarkyBoy212

prije 3 mjeseca

Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA

Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA nice news guys

Hazlaw1234

prije 3 mjeseca

$CAPR feels like one to watch very closely today 👀

The official PDUFA target date is tomorrow, Saturday 22 August, but with that falling on a weekend there’s a very real possibility we hear something from the FDA today instead. As of now there’s been no decision announced, so I’d expect a lot of eyes on CAPR once the US session gets going and especially into after hours. Could be a very important day for the stock. Definitely worth keeping notifications on. NFA

Walsemaj

prije 3 mjeseca

Lots of red today across the market

This is going back up

Lookafterthepennies

prije 3 mjeseca

Lawsuit

What’s with the rise in news of a lawsuit

Na ovoj se stranici možda nalazi sadržaj koji je izradila zajednica za koji platforma Trading 212 nije odgovorna. Uvijek sami provjerite sve informacije. Trading 212 pruža samo uslugu izvršenja i ne nudi investicijske savjete ili upravljanje portfeljem.

Ulaganje bez provizije za sve

Kupuj i prodaj Capricor Therapeutics Inc +0,06 $ (0,8 %) i više od 13.000 globalnih dionica i ETF-ova

Možda se primjenjuju druge naknade. Pogledaj naše uvjete i naknade.

Pogledaj naše uvjete i naknade ovdje

phone

Odmah kupi dionice

Odaberi svoju omiljenu tvrtku

Odluči koliko želiš uložiti

Preuzmi dionice za nekoliko sekundi

Izgradnja bogatstva je navika.
Automatiziraj je pomoću pie.

Uloži u gotove pies ili stvori vlastite odabirom među tisućama dionica i ETF-ova

Saznaj više

Saznaj više

Pogledaj video

Kupi čak i najskuplje dionice kao što su Google, Amazon i Apple

Pogledaj video

Prikaži sve instrumente trgovanja

Podrška 24/7

Prosječno vrijeme odgovora iznosi 29 sekundi

Počni graditi svoje bogatstvo sada

Pridruži se zajednici od 5 milijuna korisnika

Preuzmi aplikaciju

Otvori račun

Preuzmi mobilnu aplikaciju

qr-code

Svi prikazani statistički podaci su globalni. Broj klijenata predstavlja financirane račune.

Izvrsno

Ocjena 4,6 / 5 na osnovi 108.764 recenzije/a s platforme

Trustpilot

Ocjena 4,6 / 5 na osnovi 108.764 recenzije/a s platforme

Trustpilot

Pozvan

Great app very easy to use and lots of…

Great app very easy to use and lots of information. Always upto date with balances and share prices etc.

Pozvan

Smooth experience

The whole thing is smooth and seamless and makes things easy overall.

Pozvan

Really easy to use

Really easy to use. Secure and has the best functionality and features.

Pozvan

Easy to keep up with as informed…

Easy to keep up with as informed everyday or week on interest made . Easy to set up account . No problems .

Pozvan

Easy to operate and work with

Easy to operate and work with. Works very fast and accurately.

Pozvan

How you rate the app

This app is so easy to use and safe really love it.

Pozvan

I opened a cash ISA with them

I opened a cash ISA with them. It was really straightforward to do and interest is added daily. Nice ,easy to use app as well.

Pozvan

Easy to navigate makes investing…

Easy to navigate makes investing interesting, transferred my investments from HL which was very straightforward and now not paying dealing fee’s Very Happy

Pozvan

App is easy to work

App is easy to work Good interest rate Daily interest updates

Pozvan

Very good and informative always stay…

Very good and informative always stay on track with your investments

Pozvan

Reliable

Reliable, trustworthy app to store your money and to build on your existing wealth if you are financially sensible and smart.

Pozvan

Great app

Great app. I would recommend to anyone that’s into investing and making their money grow .

Pozvan

Very easy app to register and use

Very easy app to register and use! Really pleased.

Pozvan

Clear app

Clear app. Easy to invest. Took a whike for money to get in because i did it from bank rather than in app

Pozvan

Very smooth and user friendly

Very smooth and user friendly. Have had zero issues having moved from other brokerages. Will keep using.

Pozvan

Easy to set up and to regular monitor…

Easy to set up and to regular monitor how its performing.

Pozvan

Competitive rates and quick transfers

Very good on money transfers in and out. They take place immediately unlike some other providers. Very competitive rate on Cash ISA

Pozvan

Customer support is quick and…

Customer support is quick and effective. The app is well organised and easy to use. Would reccommend for anyone even complete beginners.

Pozvan

Easy to set up the Cash ISA

Easy to set up the Cash ISA, funds arrived in account almost immediately. Great to see interest accrual amounts daily.

Pozvan

Reliable

Reliable, Secure. Using it for past 3 years

Prikazuju se neke od pozitivnih recenzija naših klijenata

Naše nagrade

Česta pitanja

Koja je cijena dionice Capricor Therapeutics?

Trenutna cijena Capricor Therapeutics je 7,59 $.

Koji je 52-tjedni maksimum za Capricor Therapeutics?

52-tjedni maksimum za Capricor Therapeutics je 40,37 $.

Koji je 52-tjedni minimum za Capricor Therapeutics?

52-tjedni minimum za Capricor Therapeutics je 2,96 $.

Kakva je tjedna učinkovitost Capricor Therapeutics?

U proteklom tjednu cijena Capricor Therapeutics promijenila se za −20,36 %.

Kakva je mjesečna učinkovitost Capricor Therapeutics?

Tijekom proteklog mjeseca, cijena Capricor Therapeutics promijenila se za 14,14 %.

Kakva je 3-mjesečna performansa Capricor Therapeutics?

U posljednja tri mjeseca cijena Capricor Therapeutics promijenila se za −4,89 %.

Kakva je 6-mjesečna performansa Capricor Therapeutics?

U posljednjih šest mjeseci cijena Capricor Therapeutics promijenila se za −71,81 %.

Kakva je godišnja učinkovitost Capricor Therapeutics?

Tijekom protekle godine cijena Capricor Therapeutics promijenila se za 31,54 %.